<--- Back to Details
First PageDocument Content
Capsaicin / TRPV1 / TRPV / Epidermal growth factor receptor / Piquance / Colorectal cancer / Nociceptor / Capsazepine / Discovery and development of TRPV1 antagonists / Ion channels / Biology / Medicine
Date: 2014-11-28 14:38:44
Capsaicin
TRPV1
TRPV
Epidermal growth factor receptor
Piquance
Colorectal cancer
Nociceptor
Capsazepine
Discovery and development of TRPV1 antagonists
Ion channels
Biology
Medicine

Pepper and halt: Spicy chemical may inhibit gut tumors

Add to Reading List

Source URL: medicalxpress.com

Download Document from Source Website

File Size: 24,47 KB

Share Document on Facebook

Similar Documents

B’SYS GmbH  CHO TRPV1 Cell Line Specification Sheet © B’SYS GmbH

B’SYS GmbH CHO TRPV1 Cell Line Specification Sheet © B’SYS GmbH

DocID: 1q9uB - View Document

Human sensory neurons derived from iPS as a human in vitro model of peripheral pain  UMR - GMGF E. Gras Lavigne1; D. Buttigieg1; L. L’Homme1; C. Badja2; M. Ouamer1; R. Steinschneider 1; F. Magdinier2 1 Neuron Experts,

Human sensory neurons derived from iPS as a human in vitro model of peripheral pain UMR - GMGF E. Gras Lavigne1; D. Buttigieg1; L. L’Homme1; C. Badja2; M. Ouamer1; R. Steinschneider 1; F. Magdinier2 1 Neuron Experts,

DocID: 1pcm0 - View Document

Microsoft Word - Session_05_Pain and Nociception.doc

Microsoft Word - Session_05_Pain and Nociception.doc

DocID: 1gdST - View Document

Microsoft Word - Session_01-Cellular and Molecular Pharmacology.doc

Microsoft Word - Session_01-Cellular and Molecular Pharmacology.doc

DocID: 1fDjk - View Document

PHE377: A novel clinical-stage TRPV1 antagonist devoid of “class” side effects for the treatment of chronic pain syndromes Summary of the Opportunity PharmEste wishes to identify a partner for development and commerc

PHE377: A novel clinical-stage TRPV1 antagonist devoid of “class” side effects for the treatment of chronic pain syndromes Summary of the Opportunity PharmEste wishes to identify a partner for development and commerc

DocID: 1aagi - View Document